Diagnostics firms shouldn’t fear price controls: Panellists at VCCircle summit

By Beena Parmar

  • 11 Oct 2019
Premium
Credit: Pixabay

Diagnostics companies must focus on providing good-quality services and building sustainable business models instead of worrying about government moves to impose price caps on pathology tests, top industry executives said. The Indian government, as well as some states, have been considering plans to fix price limits for some diagnostics tests. The ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.